Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 1
1943 1
1945 1
1946 1
1947 5
1948 3
1949 2
1950 1
1953 2
1954 2
1956 2
1957 4
1958 2
1959 1
1961 2
1962 2
1963 1
1965 2
1966 1
1971 1
1973 1
1974 1
1976 2
1979 1
1982 1
1983 1
1984 2
1986 2
1987 1
1988 3
1989 2
1990 5
1991 4
1992 4
1993 4
1994 4
1995 2
1997 3
1998 3
2000 1
2001 2
2002 1
2003 2
2005 4
2006 5
2007 7
2008 10
2009 12
2010 13
2011 10
2012 14
2013 7
2014 11
2015 7
2016 10
2017 5
2018 10
2019 7
2020 12
2021 4
2022 7
2023 5
2024 7
2025 6
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Results by year

Filters applied: . Clear all
Page 1
Neuro-ophthalmology.
LYLE DJ. LYLE DJ. AMA Arch Ophthalmol. 1956 Nov;56(5):768-89. doi: 10.1001/archopht.1956.00930040776018. AMA Arch Ophthalmol. 1956. PMID: 13361644 No abstract available.
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
Chataway J, Williams T, Blackstone J, John N, Braisher M, De Angelis F, Bianchi A, Calvi A, Doshi A, Apap Mangion S, Wade C, Bordea E, Merry R, Barton G, Lyle D, Jarman E, Mahad D, Shehu A, Arun T, McDonnell G, Geraldes R, Craner M, Hillier C, Ganesalingam J, Fisniku L, Hobart J, Spilker C, Robertson NP, Kalra S, Pluchino S, Harikrishnan S, Mattoscio M, Harrower T, Young C, Lee M, Chhetri SK, Ahmed F, Rog D, Silber E, Gallagher P, Duddy M, Straukiene A, Nicholas R, Rice C, Tebbs S, Hawton A, Hunter R, Giovannoni G, Ciccarelli O, Beveridge J, Nixon S, Thompson AJ, Greenwood J, Pearson OR, Evangelou N, Sharrack B, Galea I, Gray E, Pavitt S, Chandran S, Ford HL, Frost C, Nicholas JM; MS-STAT2 Investigators. Chataway J, et al. Among authors: lyle d. Lancet. 2025 Oct 11;406(10512):1611-1624. doi: 10.1016/S0140-6736(25)01039-6. Epub 2025 Oct 1. Lancet. 2025. PMID: 41045938 Free article. Clinical Trial.
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial.
Pal S, Chataway J, Swingler R, Macleod MR, Carragher NO, Hardingham G, Selvaraj BT, Smith C, Wong C, Newton J, Lyle D, Stenson A, Dakin RS, Ihenacho A, Colville S, Mehta AR, Stallard N, Carpenter JR, Parker RA, Keerie C, Weir CJ, Virgo B, Morris S, Waters N, Gray B, MacDonald D, MacDonald E, Parmar MKB, Chandran S; MND SMART Investigators. Pal S, et al. Among authors: lyle d. Lancet Neurol. 2024 Nov;23(11):1097-1107. doi: 10.1016/S1474-4422(24)00326-0. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307154 Free article. Clinical Trial.
Neuro-ophthalmology.
LYLE DJ. LYLE DJ. AMA Arch Ophthalmol. 1958 Nov;60(5):950-63. doi: 10.1001/archopht.1958.00940080970017. AMA Arch Ophthalmol. 1958. PMID: 13582341 No abstract available.
Neuro-ophthalmology.
LYLE DJ. LYLE DJ. AMA Arch Ophthalmol. 1957 Nov;58(5):758-74. doi: 10.1001/archopht.1957.00940010780018. AMA Arch Ophthalmol. 1957. PMID: 13468861 No abstract available.
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.
Blackstone J, Williams T, Nicholas JM, Bordea E, De Angelis F, Bianchi A, Calvi A, Doshi A, John N, Apap Mangion S, Wade C, Merry R, Barton G, Lyle D, Jarman E, Mahad D, Shehu A, Arun T, McDonnell G, Geraldes R, Craner M, Hillier C, Ganesalingam J, Fisniku L, Hobart J, Spilker C, Robertson N, Kalra S, Pluchino S, Harikrishnan S, Mattoscio M, Harrower T, Young C, Lee M, Chhetri S, Ahmed F, Rog D, Silber E, Gallagher P, Duddy M, Straukiene A, Nicholas R, Rice C, Nixon SJ, Beveridge J, Hawton A, Tebbs S, Braisher M, Giovannoni G, Ciccarelli O, Greenwood J, Thompson AJ, Hunter R, Pavitt S, Pearson O, Evangelou N, Sharrack B, Galea I, Chandran S, Ford HL, Frost C, Chataway J. Blackstone J, et al. Among authors: lyle d. BMJ Open. 2024 Sep 16;14(9):e086414. doi: 10.1136/bmjopen-2024-086414. BMJ Open. 2024. PMID: 39284697 Free PMC article.
Ophthalmological hydrostatic pressure syndrome.
LYLE DJ, STAPP JP, BUTTON R. LYLE DJ, et al. Trans Am Ophthalmol Soc. 1956;54:121-8. Trans Am Ophthalmol Soc. 1956. PMID: 13433768 Free PMC article. No abstract available.
Reactive oxygen species in organ-specific autoimmunity.
Di Dalmazi G, Hirshberg J, Lyle D, Freij JB, Caturegli P. Di Dalmazi G, et al. Among authors: lyle d. Auto Immun Highlights. 2016 Dec;7(1):11. doi: 10.1007/s13317-016-0083-0. Epub 2016 Aug 4. Auto Immun Highlights. 2016. PMID: 27491295 Free PMC article.
249 results